Elanix Biotechnologies AG

Director's Dealing • Nov 23, 2017

News Details

Directors’ Dealings | 23 November 2017 20:07

DGAP-DD: Elanix Biotechnologies AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

23.11.2017 / 20:06

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Tomas
Last name(s):	Svoboda

2. Reason for the notification

a) Position / status

Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Elanix Biotechnologies AG

b) LEI

391200SYNFFL0NPAJK90

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Financial instrument linked to a share or a debt instrument
ISIN:	DE000A2GSU83

b) Nature of the transaction

grant of 210,065 subscription rights within capital increase

c) Price(s) and volume(s)

Price(s)	Volume(s)
0.00 EUR	0.00 EUR

d) Aggregated information

Price	Aggregated volume
0.00 EUR	0.00 EUR

e) Date of the transaction

2017-11-23; UTC+1

f) Place of the transaction

Outside a trading venue

---

23.11.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	Elanix Biotechnologies AG
	Kurfürstendamm 32
	10719 Berlin
	Germany

End of News	DGAP News Service